Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  HBM Healthcare Investments AG    HBMN   CH0012627250

HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Quote. Delayed Swiss Exchange - 12/01 11:30:58 am
286 CHF   +0.18%
11:55aHBM Healthcare Investments - Key Figures as at 30.11.2020
TE
11/16HBM Healthcare Investments - Key Figures as at 15.11.2020
TE
11/02HBM Healthcare Investments Media Release
TE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

HBM Healthcare Investments Media Release

10/30/2020 | 12:55am EST

HBM-backed Galecto raises USD 85 million in Nasdaq IPO

Galecto (Nasdaq: GLTO), a privately held company in the portfolio of HBM Healthcare Investments, completed its intended IPO. The company placed 5.67 million new shares at a price of USD 15.00 per share, raising USD 85 million in new capital. The shares closed unchanged at USD 15.00 on yesterday's first trading day.

HBM Healthcare Investments has invested USD 11.8 million in Galecto since 2018 and increased its stake in the IPO by a further USD 5 million. After the IPO, HBM Healthcare Investments holds 1.5 million shares with a total value of USD 22.4 million. As a result of the IPO, the net asset value per HBM share (NAV) increased slightly by CHF 0.59 (+0.2%).

Galecto is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis, as well as two assets about to move into Phase 2 targeting NASH and myelofibrosis. The Company is incorporated in the U.S. and has its operating headquarters in Copenhagen, Denmark.


Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.




Provider
Channel
Contact
Tensid EQS Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
cs@tensideqs.ch
+41 41 763 00 50
All news about HBM HEALTHCARE INVESTMENTS AG
11:55aHBM Healthcare Investments - Key Figures as at 30.11.2020
TE
11/16HBM Healthcare Investments - Key Figures as at 15.11.2020
TE
11/02HBM Healthcare Investments Media Release
TE
11/02HBM Healthcare Investments - Key Figures as at 31.10.2020
TE
10/30HBM Healthcare Investments Media Release
TE
10/28HBM Healthcare Investments Media Release
TE
10/23HBM Healthcare Investments Media Release
TE
10/16HBM Healthcare Investments - Key Figures as at 15.10.2020
TE
10/09HBM Healthcare Investments Media Release
TE
10/05HBM Healthcare Investments Media Release
TE
More news
Financials
Sales 2021 - - -
Net income 2021 262 M 291 M 291 M
Net Debt 2021 98,0 M 109 M 109 M
P/E ratio 2021 7,60x
Yield 2021 3,08%
Capitalization 1 990 M 2 208 M 2 212 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 700
Free-Float 83,0%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 264,00 CHF
Last Close Price 286,00 CHF
Spread / Highest target -7,69%
Spread / Average Target -7,69%
Spread / Lowest Target -7,69%
EPS Revisions
Managers
NameTitle
Andreas Wicki Chief Executive Officer
Hans-Peter Hasler Chairman
Erwin Troxler Chief Financial Officer
Heinz Riesenhuber Vice Chairman
Eduard Enrico Holdener Director
Sector and Competitors
1st jan.Capitalization (M$)
HBM HEALTHCARE INVESTMENTS AG28.31%2 192
BLACKROCK, INC.38.92%106 506
BROOKFIELD ASSET MANAGEMENT INC.6.54%62 209
UBS GROUP AG5.44%51 032
THE BLACKSTONE GROUP INC.6.45%41 326
BANK OF NEW YORK MELLON CORPORATION (THE)-22.27%34 666